• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

    2/13/24 4:55:53 PM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email
    SC 13G/A 1 tv0055-dupontdenemoursinc.htm SCHEDULE 13G/A dupontdenemoursinc

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 7)*

    Name of issuer:  DuPont de Nemours Inc

    Title of Class of Securities:  Common Stock

    CUSIP Number:  26614N102

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  26614N102

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    555,323

    7.  SOLE DISPOSITIVE POWER

    46,182,292

    8.  SHARED DISPOSITIVE POWER

    1,861,570

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    48,043,862

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    11.17%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    DuPont de Nemours Inc

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    974 Centre Road, Building 730
    Wilmington, DE 19805

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    26614N102

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $DD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    5/23/2024$96.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DuPont Completes Qnity™ Board of Directors

      Mark Blinn announced as director and chairman and Yi Hyon Paik as director WILMINGTON, Del., June 11, 2025  /PRNewswire/ -- DuPont (NYSE:DD) today announced that Mark A. Blinn and Dr. Yi Hyon Paik will become members of the future board of directors (the "Qnity Board") for Qnity Electronics, Inc., the planned, independent Electronics public company created from DuPont's intended spin-off.* Mr. Blinn will become chairman of the Qnity Board effective with the spin-off. Mr. Blinn was chief executive officer, president, and director of Flowserve Corporation until his retirement in

      6/11/25 8:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Innovators in Semiconductor Materials Named 2025 Heroes of Chemistry

      Breakthrough in Semiconductor Lithography Recognized by the American Chemical Society WILMINGTON, Del., June 10, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that 13 of its current and former scientists and engineers have been named 2025 Heroes of Chemistry by the American Chemical Society (ACS) for an innovative program that progressed semiconductor lithography. The award recognizes the collaborative development of embedded barrier layer technology, a transformative advancement in 193 nm immersion lithography that significantly improved chip fabrication processes by

      6/10/25 11:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Expands Healthcare Manufacturing Site in Costa Rica, Adding Sterile Packaging Capacity

      The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever production of sterile healthcare packaging. WILMINGTON, Del., June 5, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica, enabling the site to produce sterile packaging for the global medical device industry while also increasing the capacity of the site's existing medical tubing operations.

      6/5/25 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials